Small Molecule/HLA Complexes Alter the Cellular Proteomic Content
A medical product usually undergoes several clinical trials, including the testing of volunteers. Nevertheless, genomic variances in the patients cannot be considered comprehensively and adverse drug reactions (ADRs) are missed or misinterpreted during trials. Despite the relation between ADRs and h...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/76381 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Small Molecule/HLA Complexes Alter the Cellular Proteomic Content
- HLA Class I Polymorphism and Tapasin Dependency
- Relevance of HLA Expression Variants in Stem Cell Transplantation
- Cerebral Ischemia Induced Proteomic Alterations: Consequences for the Synapse and Organelles
- HLA-E, HLA-F and HLA-G — The Non-Classical Side of the MHC Cluster
- A unified cross-attention model for predicting antigen binding specificity to both HLA and TCR molecules
- TripHLApan: predicting HLA molecules binding peptides based on triple coding matrix and transfer learning